SEC Form 4 · accession 0000899243-18-015111
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Cima
Director
Period of report
Jun 2, 2018
Accepted (ET)
Jun 5, 2018 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 2, 2018 | M | 18,000 | — | A | 207,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 2, 2017 | M | 18,000 | A | — | — | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- F2On June 2, 2017 the reporting person was granted 18,000 RSUs that vested on June 2, 2018.